// App-Quantinova.ai

PB0505 : Severe Haemophilia A Plasma Artificially Spiked with Emicizumab and Recombinant Factor VIII Concentrates: Measurement by One-Stage and Chromogenic Factor VIII Assays

Researchers

Presenter

  • A. Bowyer

Principal Investigators

  • S. Kitchen

  • R. Wardle

  • R. Maclean

Medical Centers

  • Sheffield Teaching Hospitals, Department of Coagulation, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • Activated partial thromboplastin time

Drug/Treatment

  • Recombinant Factor VIII

  • ReFacto

  • Advate

  • Elocta

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved